Elevated serum markers for collagen synthesis in patients with hypertrophic cardiomyopathy and diastolic dysfunction (Q81709672)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868361%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

Elevated serum markers for collagen synthesis in patients with hypertrophic cardiomyopathy and diastolic dysfunction (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868361%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

hypertrophic cardiomyopathy

1 reference

1 reference

1 reference

M Fassbach

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868361%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

B Schwartzkopff

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868361%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

1 May 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868361%20AND%20SRC:MED&resulttype=core&format=json

Clinical Research in Cardiology

11 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868361%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868361%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868361%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

328-335

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868361%20AND%20SRC:MED&resulttype=core&format=json

Alterations of the architecture of subendocardial arterioles in patients with hypertrophic cardiomyopathy and impaired coronary vasodilator reserve: a possible cause for myocardial ischemia.

11 January 2020

cites work

1 reference

12 December 2020

Cardiac fibrosis as a cause of diastolic dysfunction

1 reference

12 December 2020

Myocardial collagen type I and impaired left ventricular function under exercise in hypertrophic cardiomyopathy

1 reference

12 December 2020

Abnormalities of the extracellular degradation of collagen type I in essential hypertension

1 reference

12 December 2020

Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy

1 reference

12 December 2020

Elevated serum markers of collagen degradation in patients with mild to moderate dilated cardiomyopathy

1 reference

12 December 2020

Hormonal regulation of cardiac fibroblast function

1 reference

12 December 2020

Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy

1 reference

12 December 2020

Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix

1 reference

12 December 2020

Morphologic evidence for "small vessel disease" in patients with hypertrophic cardiomyopathy

1 reference

12 December 2020

Mechanisms of exercise limitation in hypertrophic cardiomyopathy

1 reference

12 December 2020

Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements

1 reference

12 December 2020

Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone

1 reference

12 December 2020

Toward the biochemical assessment of myocardial fibrosis in hypertensive patients

1 reference

12 December 2020

Reversal of left ventricular hypertrophy and improvement of cardiac function in man by nifedipine

1 reference

12 December 2020

Pathologic fibrosis and matrix connective tissue in the subaortic myocardium of patients with hypertrophic cardiomyopathy

1 reference

12 December 2020

Simultaneous hypertrophic obstructive cardiomyopathy and long QT syndrome: a potentially malignant association

1 reference

12 December 2020

Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy

1 reference

12 December 2020

Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults

1 reference

12 December 2020

Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death

1 reference

12 December 2020

Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance.

1 reference

12 December 2020

Fabry disease in patients with hypertrophic cardiomyopathy (HCM).

1 reference

12 December 2020

Apical hypertrophic cardiomyopathy due to a de novo mutation Arg719Trp of the b-myosin heavy chain gene and cardiac arrest in childhood A case report and family study

1 reference

12 December 2020

Matrix metalloproteinase activity expression in infarcted, noninfarcted and dilated cardiomyopathic human hearts

1 reference

12 December 2020

Dilated cardiomyopathies of the adult (first of two parts).

1 reference

12 December 2020

Exercise capacity in hypertrophic cardiomyopathy depends on left ventricular diastolic function

1 reference

12 December 2020

Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry

1 reference

12 December 2020

Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients

1 reference

12 December 2020

Endocardial radiofrequency ablation of septal hypertrophy. A new catheter-based modality of gradient reduction in hypertrophic obstructive cardiomyopathy

1 reference

12 December 2020

Hypertrophic cardiomyopathy. Clinical spectrum and treatment.

1 reference

12 December 2020

Prediction of the site and severity of obstruction in hypertrophic cardiomyopathy by color flow mapping and continuous wave Doppler echocardiography

1 reference

12 December 2020

Co-expression of tissue inhibitor and matrix metalloproteinase in myocardium

1 reference

12 December 2020

Diagnostic significance of impaired LV systolic relaxation in heart failure

1 reference

12 December 2020

Matrix metalloproteinase inhibition during the development of congestive heart failure : effects on left ventricular dimensions and function

1 reference

12 December 2020

Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathy

1 reference

12 December 2020

10.1007/S00392-005-0214-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868361%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference